Audentes Therapeutics SEC Filings http://investors.audentestx.com/ Audentes Therapeutics SEC Filings en 4: Statement of changes in beneficial ownership of securities http://investors.audentestx.com/sec-filings/sec-filing/4/0001209191-19-035588 Audentes Therapeutics, Inc. Fri, 07 Jun 2019 16:45:45 -0400 Audentes Therapeutics SEC Filings 8731 4: Statement of changes in beneficial ownership of securities http://investors.audentestx.com/sec-filings/sec-filing/4/0001209191-19-035586 Audentes Therapeutics, Inc. Fri, 07 Jun 2019 16:45:45 -0400 Audentes Therapeutics SEC Filings 8736 4: Statement of changes in beneficial ownership of securities http://investors.audentestx.com/sec-filings/sec-filing/4/0001209191-19-035584 Audentes Therapeutics, Inc. Fri, 07 Jun 2019 16:43:45 -0400 Audentes Therapeutics SEC Filings 8721 4: Statement of changes in beneficial ownership of securities http://investors.audentestx.com/sec-filings/sec-filing/4/0001209191-19-035578 Audentes Therapeutics, Inc. Fri, 07 Jun 2019 16:43:45 -0400 Audentes Therapeutics SEC Filings 8726 8-K: Report of unscheduled material events or corporate event http://investors.audentestx.com/sec-filings/sec-filing/8-k/0001628280-19-007731 Audentes Therapeutics, Inc. Fri, 07 Jun 2019 16:33:46 -0400 Audentes Therapeutics SEC Filings 8716 8-K: Report of unscheduled material events or corporate event http://investors.audentestx.com/sec-filings/sec-filing/8-k/0001628280-19-007304 Audentes Therapeutics, Inc. Wed, 29 May 2019 16:08:24 -0400 Audentes Therapeutics SEC Filings 8711 4: Statement of changes in beneficial ownership of securities http://investors.audentestx.com/sec-filings/sec-filing/4/0001209191-19-030040 Audentes Therapeutics, Inc. Wed, 15 May 2019 17:11:15 -0400 Audentes Therapeutics SEC Filings 8701 S-8: Securities offered to employees pursuant to employee benefit plans http://investors.audentestx.com/sec-filings/sec-filing/s-8/0001628280-19-006595 Audentes Therapeutics, Inc. Mon, 13 May 2019 06:06:13 -0400 Audentes Therapeutics SEC Filings 8696 10-Q: Quarterly report which provides a continuing view of a company's financial position http://investors.audentestx.com/sec-filings/sec-filing/10-q/0001628280-19-006182 Audentes Therapeutics, Inc. Wed, 08 May 2019 06:45:56 -0400 Audentes Therapeutics SEC Filings 8681 8-K: Report of unscheduled material events or corporate event http://investors.audentestx.com/sec-filings/sec-filing/8-k/0001628280-19-006048 Audentes Therapeutics, Inc. Tue, 07 May 2019 16:07:18 -0400 Audentes Therapeutics SEC Filings 8676